Five Prime Founder Rusty Williams Returns With Walking Fish Therapeutics

Focusing On B-Cell Therapies

 
• By Andrew McConaghie

Named after a remarkable self-regenerating salamander, the new San Francisco biotech aims to unlock the potential of B-cells to be “in vivo protein factories”.

Walking Fish Therapeutics
The company's $50m Series A financing has been led by investors including Emerson Collective, Illumina and Quan Capital.

More from Business

More from Scrip